Jw Pharmac Total Assets

Latest as of March 2026: ₩621.61 Billion KRW ≈ $421.25 Million USD

Jw Pharmac total assets. Based on the latest financial reports, Jw Pharmac (001060) holds total assets worth ₩621.61 Billion KRW (≈ $421.25 Million USD) as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Also see 001060 company net worth for the company's overall valuation and market capitalisation.

Total Assets of Jw Pharmac (2000–2025)

Total assets of Jw Pharmac from 2000 to 2025. This chart illustrates how Jw Pharmac's total assets have evolved over time, based on quarterly financial data. See Jw Pharmac (001060) stock price for real-time trading data and today's change.

Jw Pharmac - Asset Composition Analysis

Jw Pharmac Total Assets Breakdown (December 2025)

Jw Pharmac total assets breakdown as of December 2025. Jw Pharmac's total assets of ₩621.61 Billion consist of 49.0% current assets and 51.0% non-current assets.

Asset Category	Amount (KRW)	% of Total Assets
Cash & Equivalents	₩0.00	6.5%
Accounts Receivable	₩114.57 Billion	18.9%
Inventory	₩109.90 Billion	18.2%
Property, Plant & Equipment	₩0.00	0.0%
Intangible Assets	₩64.46 Billion	10.7%
Goodwill	₩0.00	0.0%

Asset Composition Trend (2000–2025)

This chart illustrates how Jw Pharmac's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. Explore Jw Pharmac (001060) liquidity to equity ratio to assess how much short-term liquidity the company maintains relative to its equity base.

Show as percentage

Key Asset Composition Facts

Current vs. Non-Current Assets: Jw Pharmac's current assets represent 49.0% of total assets in 2025, an increase from 0.0% in 2000.
Cash Position: Cash and equivalents constituted 6.5% of total assets in 2025, down from 15.1% in 2000.
Tangible vs. Intangible: Intangible assets (including goodwill) make up 10.0% of total assets, an increase from 0.0% in 2000.
Asset Diversification: The largest asset category is accounts receivable at 18.9% of total assets.

Jw Pharmac Competitors by Total Assets

Key competitors of Jw Pharmac based on total assets are shown below.

Company	Country	Total Assets
Viatris Inc NASDAQ:VTRS	USA	$35.04 Billion
Tianjin Zhongxin Pharmaceutical Group Corp Ltd SHG:600329	China	CN¥11.59 Billion
Walvax BioTech SHE:300142	China	CN¥10.50 Billion
Curaleaf Holdings Inc. TO:CURA	Canada	CA$2.88 Billion
Tianjin Chase Sun Pharmaceutical Co Ltd SHE:300026	China	CN¥10.37 Billion
Changzhou Qianhong Biopharma Co Ltd SHE:002550	China	CN¥3.23 Billion
Renhe Pharmacy Co Ltd SHE:000650	China	CN¥7.93 Billion
Harbin Gloria Pharmaceuticals SHE:002437	China	CN¥3.14 Billion

Jw Pharmac - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric	Current	1 Year Ago	5 Years Ago
Current Ratio	1.46	1.48	1.39
Quick Ratio	0.92	0.92	0.95
Cash Ratio	0.00	0.00	0.00
Working Capital	₩97.54 Billion	₩104.34 Billion	₩95.65 Billion

Jw Pharmac - Advanced Valuation Insights

This section examines the relationship between Jw Pharmac's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio	1.60
Latest Market Cap to Assets Ratio	0.00
Asset Growth Rate (YoY)	0.1%
Total Assets	₩605.27 Billion
Market Capitalization	$349.95 Million USD

Valuation Analysis

Below Book Valuation: The market values Jw Pharmac's assets below their book value (0.00x), which may indicate investor concerns about asset quality or future growth.

Positive Asset Growth: Jw Pharmac's assets grew by 0.1% over the past year, showing continued investment in the company's operational capacity.

Annual Total Assets for Jw Pharmac (2000–2025)

The table below shows the annual total assets of Jw Pharmac from 2000 to 2025.

Year	Total Assets	Change
2025-12-31	₩605.27 Billion ≈ $410.18 Million	+0.11%
2024-12-31	₩604.60 Billion ≈ $409.73 Million	-6.27%
2023-12-31	₩645.04 Billion ≈ $437.13 Million	+2.72%
2022-12-31	₩627.97 Billion ≈ $425.57 Million	-0.80%
2021-12-31	₩633.05 Billion ≈ $429.01 Million	+15.29%
2020-12-31	₩549.09 Billion ≈ $372.11 Million	-4.21%
2019-12-31	₩573.21 Billion ≈ $388.45 Million	-3.47%
2018-12-31	₩593.79 Billion ≈ $402.40 Million	-5.88%
2017-12-31	₩630.87 Billion ≈ $427.53 Million	-3.10%
2016-12-31	₩651.08 Billion ≈ $441.23 Million	+6.13%
2015-12-31	₩613.48 Billion ≈ $415.75 Million	+3.26%
2014-12-31	₩594.12 Billion ≈ $402.63 Million	+0.81%
2013-12-31	₩589.37 Billion ≈ $399.41 Million	-2.28%
2012-12-31	₩603.15 Billion ≈ $408.74 Million	-9.59%
2011-12-31	₩667.09 Billion ≈ $452.08 Million	+29.32%
2006-12-31	₩515.85 Billion ≈ $349.58 Million	+7.92%
2005-12-31	₩477.97 Billion ≈ $323.91 Million	+4.46%
2004-12-31	₩457.56 Billion ≈ $310.08 Million	+11.06%
2003-12-31	₩412.00 Billion ≈ $279.21 Million	+6.85%
2002-12-31	₩385.60 Billion ≈ $261.32 Million	+0.08%
2001-12-31	₩385.28 Billion ≈ $261.10 Million	-3.06%
2000-12-31	₩397.46 Billion ≈ $269.35 Million	--

About Jw Pharmac

KO:001060 Korea Drug Manufacturers - Specialty & Generic

Market Cap

$349.95 Million

₩516.38 Billion KRW

Market Cap Rank

#13794 Global

#415 in Korea

Share Price

₩22900.00

Change (1 day)

-0.43%

52-Week Range

₩22000.00 - ₩39050.00

All Time High

₩75306.05